Next Article in Journal
Safety Evaluation of Cosmetic Ingredients Regarding Their Skin Sensitization Potential
Next Article in Special Issue
Human Hair and the Impact of Cosmetic Procedures: A Review on Cleansing and Shape-Modulating Cosmetics
Previous Article in Journal
Erratum: Fitton, J.H., et al. Topical Benefits of Two Fucoidan-Rich Extracts from Marine Macroalgae. Cosmetics 2015, 2, 66–81
Article Menu

Export Article

Open AccessReview
Cosmetics 2016, 3(2), 13; doi:10.3390/cosmetics3020013

Telogen Effluvium

1
Sinclair Dermatology, Melbourne 3002, Australia
2
Department of Dermatology, University of Melbourne, Melbourne 3002, Australia
*
Author to whom correspondence should be addressed.
Academic Editor: Won-Soo Lee
Received: 20 February 2016 / Revised: 21 March 2016 / Accepted: 21 March 2016 / Published: 25 March 2016
(This article belongs to the Special Issue Hair Care Cosmetics)
View Full-Text   |   Download PDF [858 KB, uploaded 25 March 2016]   |  

Abstract

Kligman first coined the term telogen effluvium (TE) in 1961 to describe the state of increased shedding of otherwise normal telogen hairs. TE may be primary or secondary to a wide variety of potential triggers including febrile illness, drugs, thyroid disorders, and child birth. The diagnosis of secondary TE can be made by identifying known triggers from the history in the 3–4 months preceding the onset of increased hair shedding and by investigating to exclude endocrine, nutritional, or auto immune aetiologies. Scalp biopsy to identify the earliest stages of androgenetic alopecia may be required in some cases. Primary TE may be acute or chronic. In acute TE, the shedding resolves within 3–6 months and the hair density recovers completely. In chronic TE, the shedding can continue with minor fluctuations in severity for decades. In this review, possible causative factors, pathogenesis, clinical presentations and treatment options are discussed. View Full-Text
Keywords: diffuse hair loss; telogen effluvium; minoxidil diffuse hair loss; telogen effluvium; minoxidil
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Liyanage, D.; Sinclair, R. Telogen Effluvium. Cosmetics 2016, 3, 13.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cosmetics EISSN 2079-9284 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top